Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide added to Glatiramer Acetate in Multiple Sclerosis
NCT00475865Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2007
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Apr 2007; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00475865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475865.